Oxford Biomedica Plc

Oxford Biomedica (OXB)

Buy
Sell
Company name:Oxford Biomedica Plc
EPIC:OXBTrading Currency:GBX
Market Sector:SSC5ISIN:GB00BDFBVT43
Market Segment:SSMMShare Type:DE
WWW Address:http://www.oxfordbiomedica.co.uk/Description:ORD 50P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 481.00 images.advfn.com/imagesnew/2/gb/down -2.0 [-0.41] 482.00 484.50 484.00 495.50 473.50 95,753
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 462.06 96.06 0.06 22.77 - 21.12 - 1,678.00 - 414.00

Oxford Biomedica Key Figures

(at previous day's close)
Market Cap.462.06m
Shares In Issue96.06m
Prev. Close483.00
PE Ratio21.12 
Dividend Yield-%
EPS - basic22.77p
Dividend PS-p
Dividend Cover- 
Cash Flow PS26.50p
Return On Equity (ROE)10.15%
Operating Margin13.92%
PEG Factor0.05 
EPS Growth Rate391.55%
Dividends PS Growth Rate-%
Net Debt-59.05m
Gross Gearing21.03%
Quick Assets157.93m
Net Working Capital134.14m
Intangibles / Fixed Assets0.07%
Turnover PS148.65p
Pre-Tax Profit PS20.69p
Retained Profit PS19.79p
Cash PS113.41p
Net Cash PS78.74p
Net Tangible Asset Value PS *194.96p
Net Asset Value PS195.02p
Spread2.50 (0.52%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Oxford Biomedica Balance Sheet

L^OXB:Liabilities+EQL^OXB:Assets

Share Price Performance

Sample Period †HighLow
1 week495.50414.00
4 weeks527.00414.00
12 weeks679.00414.00
1 year1,678.00414.00

Share Price Chart (5 years)

Oxford Biomedica Historic Returns

Period †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week441.0040.009.07414.000.41426.11
4 weeks527.00-46.00-8.73414.000.24453.09
12 weeks679.00-198.00-29.16414.000.21512.12
26 weeks1,208.00-727.00-60.18414.000.19657.28
1 year1,284.00-803.00-62.54414.000.181,001.79
3 years730.00-249.00-34.11366.000.16886.40
5 years275.00206.0074.91272.501.73533.63
† periods calculated are whole weeks rather than calendar months

Oxford Biomedica Key Management Ratios

Oxford Biomedica Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio3.82 
PE Ratio21.12 
Tobin's Q Ratio 2.19 
Tobin's Q Ratio (excl. intangibles)2.19 
Dividend Yield-%
Market-to-Book Ratio2.47 
Price-to-Pre-Tax Profit PS23.24 
Price-to-Retained Profit PS24.30 
Price-to-Cash Flow PS18.15 
Price-to-Sales PS3.24 
Price-to-Net Tangible Asset Value PS2.47 
Price-to-Cash PS4.24 
Net Working Capital PS139.64 
Price Pct to Working Capital PS3.44%
Earnings Yield4.73%
Average PE57.57 
Years in average2 
PE to PE average36.69%

Oxford Biomedica Financial Ratios

(Leverage Ratios)
Debt Ratio8.13%
Debt-to-Equity Ratio0.09 
Debt-to-Equity Ratio (excl. Intgbl)0.09 
Debt-to-Equity Market Value0.04 
Net Gearing-24.89%
Net Gearing (excl. Intangibles)-24.90%
Gross Gearing21.03%
Gross Gearing (excl. Intangibles)21.04%
Gearing Under 1 Year14.04%
Gearing Under 1 Year (excl. Intgbl)14.04%
Assets/Equity1.27 
Cash/Equity58.15 
(Liquidity Ratios)
Net Working Capital to Total Assets56.55%
Current Ratio5.03 
Quick Ratio (Acid Test)4.74 
Liquidity Ratio3.27 
Cash & Equiv/Current Assets65.06%
(Solvency Ratios)
Enterprise Value369.70m
CFO/Sales0.18 
CFO/Attributable Profit1.34 
CFO/Assets0.11 
CFO/Debt0.51 
Total Debt/Equity Market Value0.11 
Total Debt/Sales0.35 
Total Debt/Pre-Tax Profit2.51 
Total Debt49.89m
Total Debt/Net Current Assets0.37%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs9 
Beta (60-Mnth)Beta (36-Mnth)
0.05690.1914

Oxford Biomedica Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)9.75%
Return On Assets (ROA)9.03%
Net Profit Margin13.31%
Assets Turnover0.68 
Return On Equity (ROE)10.15%
Return On Investment (ROI)11.34%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio12.67%
Net Income Of Revenues13.31%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.95 
Fixed Assets Turnover2.01 
Current Assets Turnover1.02 
Net Working Capital Turnover 
Inventory Turnover17.38 
(Other Operating Ratios)
Total Assets-to-Sales1.47 
Debtors-to-Sales37.31%
Debt Collection Period136.20Days

Oxford Biomedica Dividends

Sorry No Data Available

Oxford Biomedica Fundamentals
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
turnover66.78100.00%64.06100.00%87.73100.00%142.80100.00%m
pre tax profit5.017.51%-20.89-32.61%-6.57-7.49%19.8813.92%m
attributable profit7.5411.29%-16.07-25.08%-6.25-7.12%19.0113.31%m
retained profit7.5411.29%-1.61-2.51%-6.25-7.12%19.0113.31%m
eps - basic (p)11.57 -22.10 -7.81 22.77 
eps - diluted (p)10.89 -22.10 -7.81 22.20 
dividends per share- - - - 

Oxford Biomedica Balance Sheet

 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
L^OXB:Liabilities+EQL^OXB:AssetsL^OXB:Liabilities+EQL^OXB:AssetsL^OXB:Liabilities+EQL^OXB:AssetsL^OXB:Liabilities+EQL^OXB:Assets
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
ASSETS
fixed assets fixed assets31.7928.28%61.9350.38%72.3039.31%69.7329.39%m
intangibles intangibles0.120.10%0.100.08%0.070.04%0.050.02%m
fixed investments fixed investments10.979.76%--%--%--%m
current assets - other current assets - other--%2.722.21%0.240.13%0.070.03%m
stocks stocks4.253.78%2.582.10%6.913.76%9.524.01%m
debtors debtors33.0329.39%39.3632.02%57.6631.35%48.9120.62%m
cash & securities cash & securities32.2428.69%16.2413.21%46.7425.41%108.9445.92%m
TOTAL112.40100%122.93100%183.93100%237.23100%m
LIABILITIES
creditors - short creditors - short28.5125.36%28.9423.54%52.4628.52%33.3114.04%m
creditors - long creditors - long49.1543.73%18.3614.93%18.7310.18%16.586.99%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL77.6669.09%47.3038.48%71.1838.70%49.8921.03%m
EQUITY
ord cap, reserves ord cap, reserves34.7430.91%75.6361.52%112.7561.30%187.3478.97%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL34.7430.91%75.6361.52%112.7561.30%187.3478.97%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Oxford Biomedica Cash Flow Statement

31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
Operating CF12.87-3.513.1225.46m
Pre-Financing CF2.77-22.91-7.6915.99m
Retained CF17.92-16.0030.5062.20m

Oxford Biomedica Brokers

NameActivityTypeMnemonicCode
J.P. Morgan Cazenove LimitedMarket Maker(MME)Broker/DealerCAZRCAZEGB2L
Nomura Code Securities LimitedMarket Maker(MME)Broker/DealerCODECODCGB21
Collins Stewart Europe LimitedMarket Maker(MME)Broker/DealerCSCSCSTEGB21
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MME)Broker/DealerCANAHOARGB21001
Liberum Capital LimitedMarket Maker(MME)Broker/DealerLIBCLCAPGB21
Panmure Gordon (UK) LimitedMarket Maker(MME)Broker/DealerPMURPMURGB2L
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
LSE
OXB
Oxford Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220625 10:29:12